Professor, Pathology-Brigham and Women's Hospital, Harvard Medical School
Pathology
Dr. George L. Mutter, MD
|
|
Give Review
George Mutter is an expert in the field of Pathology. He went to Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School has a rank of 1 in research and a 12 in primary care George Mutter is a published doctor. He has 37 papers published. The most current publication "Sperm processing for advanced reproductive technologies: Where are we today?" George Mutter accepts Medicare.
Publications
- Biomarker resolution of uterine smooth muscle tumor necrosis as benign vs malignant.
- ARID1A is a useful marker of malignancy in peritoneal washings for endometrial carcinoma.
- Selection of Functional Human Sperm with Higher DNA Integrity and Fewer Reactive Oxygen Species.
- Endometrial intraepithelial neoplasia with secretory differentiation: diagnostic features and underlying mechanisms.
- Endometrial intraepithelial neoplasia clinical correlates and outcomes.
- Clinical outcome in diagnostically ambiguous foci of 'gland crowding' in the endometrium.
- High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression.
- Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer.
- Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance.
- Involution of latent endometrial precancers by hormonal and nonhormonal mechanisms.
- Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator.
- Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma.
- Squamous morules are functionally inert elements of premalignant endometrial neoplasia.
- Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.
- Histologic and immunohistochemical decision-making in endometrial adenocarcinoma.
- PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma.
- The spectrum of endometrial pathology induced by progesterone receptor modulators.
- Breast-cancer stromal cells with TP53 mutations and nodal metastases.
- Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma.
- Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia.
- Molecular and pathologic aspects of endometrial carcinogenesis.
- Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation.
- Regression of latent endometrial precancers by progestin infiltrated intrauterine device.
- The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more a...
- Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression.
- Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis.
- Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets.
- Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
- Involution of PTEN-null endometrial glands with progestin therapy.
- Hertig and beyond: a systematic and practical approach to the endometrial biopsy.
- Identification of differentially expressed genes in high-density oligonucleotide arrays accounting for the quantification limits of the technology.
- Factors associated with disposition of cryopreserved reproductive tissue.
- Biomarkers in diagnostic obstetric and gynecologic pathology: a review.
- p63 Coordinates anogenital modeling and epithelial cell differentiation in the developing female urogenital tract.
- Estradiol-induced hyperplasia in endometrial biopsies from women on hormone replacement therapy.
- Sperm processing for advanced reproductive technologies: Where are we today?
Schools
Harvard Medical School
Colum Presby Med Center
Doctors Specialties
- Anatomic Pathology
- Pathology
Accepted Insurances
Education
-
New York Presbyterian Hospital - Columbia Campus -
Harvard Medical School
Hospital
-
Brigham and Women's Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1023074325 |
| Last Name Of The Provider | MUTTER |
| First Name Of The Provider | GEORGE |
| View All |
Similar Doctors
|
|
Dr. Melinda J. Lerwill, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sherrie R. White, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark A. Rubin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marisa R. Nucci, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Andrew H. Lichtman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jeffrey F. Krane, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle S. Hirsch, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Leona A. Doyle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ambrose F. Keeley, MD |